Related references
Note: Only part of the references are listed.Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients
Hui Shang et al.
MEDICAL SCIENCE MONITOR (2021)
Long non-coding RNA CIR inhibits chondrogenic differentiation of mesenchymal stem cells by epigenetically suppressing ATOH8 via methyltransferase EZH2
Feng Liu et al.
MOLECULAR MEDICINE (2021)
Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?
Juan Eduardo Megias-Vericat et al.
BLOOD REVIEWS (2020)
LncRNA FTX activates FOXA2 expression to inhibit non-small-cell lung cancer proliferation and metastasis
Shidai Jin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Quizartinib for the treatment of acute myeloid leukemia
Alejandro Garcia-Horton et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Cutting Edge Molecular Therapy for Acute Myeloid Leukemia
Kenichi Miyamoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
Vanessa E. Kennedy et al.
FRONTIERS IN ONCOLOGY (2020)
New directions for emerging therapies in acute myeloid leukemia: the next chapter
Naval Daver et al.
BLOOD CANCER JOURNAL (2020)
A non-viral nano-delivery system targeting epigenetic methyltransferase EZH2 for precise acute myeloid leukemia therapy
Babita Kaundal et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
EZH2 Confers Sensitivity of Breast Cancer Cells to Taxol by Attenuating p21 Expression Epigenetically
Xin Mu et al.
DNA AND CELL BIOLOGY (2019)
Quizartinib (AC220): a promising option for acute myeloid leukemia
Fang Zhou et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3
Jinman Kim et al.
CELL REPORTS (2018)
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
Stefanie Goellner et al.
NATURE MEDICINE (2017)
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia
Nina Fenouille et al.
NATURE MEDICINE (2017)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
R. M. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
Jacob L. Glass et al.
CANCER DISCOVERY (2017)
Genetic and epigenetic heterogeneity in acute myeloid leukemia
Sheng Li et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells
Kuan-Chun Huang et al.
EUROPEAN JOURNAL OF CANCER (2016)
The genomic landscape of core-binding factor acute myeloid leukemias
Zachary J. Faber et al.
NATURE GENETICS (2016)
Novel Therapeutics for Therapy-Related Acute Myeloid Leukemia: 2014
Eric J. Feldman
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging
Binje Vick et al.
PLOS ONE (2015)
Integrative analysis of histone ChIP-seq and transcription data using Bayesian mixture models
Hans-Ulrich Klein et al.
BIOINFORMATICS (2014)
DNAMethylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors
Jovana Klajic et al.
CLINICAL CANCER RESEARCH (2014)
Mechanisms of resistance against PKC412 in resistant FLT3-ITD positive human acute myeloid leukemia cells
Friedrich Stoelzel et al.
ANNALS OF HEMATOLOGY (2010)
DNA damage response involves modulation of Ku70 and Rb functions by cyclin A1 in leukemia cells
Ping Ji et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia
T Büchner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia
C Holm et al.
LEUKEMIA RESEARCH (2006)
Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells
P Ji et al.
ONCOGENE (2005)
Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival
T Nakamaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Share Paper
